SARS-CoV-2, a mutation of COV-19, has been tracked in China since January. Currently the mutation does not appear to make the virus any more deadly than it already is, but it does appear to make it significantly more contagious. (Biospace)...
Read More
Drug makers selected for “Operation Warp Speed,” the White House’s ambitious plan to develop a coronavirus vaccine in record time, will enjoy priority access to manufacturing capacity secured by the U.S. government, as well as to needed supplies...
The coronavirus epidemic in the U.S. is expanding and the U.S. still has not put the necessary infrastructure in place to prevent a major second wave in the fall, former FDA Commissioner Dr. Scott Gottlieb says. He said Tennessee,...
While the restart of elective procedures will follow regional timelines, and the pace at which consumers will feel comfortable returning to healthcare settings is uncertain, hospitals, nurses and the medical device industry are now laying the groundwork to prepare for...
Drugmakers, medical research and healthcare organizations involved with the response to the Covid-19 pandemic have been victims of state-backed hacking campaigns, cybersecurity bodies in the U.S. and U.K. have warned. (Medcitynews) In particular, Bright claimed his involuntary transfer...
Jerusalem-based OurCrowd announced today that it would lead a $12 million investment in the newly formed startup MigVax, an affiliate of The Migal Galilee Research Institute. The institute has previously developed a vaccine against a Coronavirus strain which causes bronchial disease affecting poultry....
English